Outcomes in dialysis: a global assessment

  • D. Bottalico
  • F. K. Port
  • F. P. Schena


More than 50 years have passed since the first uremic patient was treated with hemodialysis (HD). Soon after, HD was available to treat acute renal failure. However, maintenance HD did not become a reality for patients with end-stage renal disease (ESRD) before 1960, when indwelling arteriovenous Teflon shunt therapy, or Quinton-Scribner shunt therapy, was developed. At about the same time advances in immunosuppression, such as the development of 6-mercaptopurine and its derivative, azathioprine sodium, led to the modern era of kidney transplantation.


Diabetic Nephropathy Dialysis Patient ESRD Patient Continuous Ambulatory Peritoneal Dialysis Continuous Ambulatory Peritoneal Dialysis Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Akmal M. Hemodialysis in diabetic patients. Am J Kidney Dis. 2001;38(Suppl. 1):S195–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Miskulin DC, Athienites NV, Yan G et al. Comorbidity assessment using the Index of Coexistent Diseases in a multicenter clinical trial. Kidney Int. 2001;60:1498–510.PubMedCrossRefGoogle Scholar
  3. 3.
    Valderrabano F, Jofre R, Lopez-Gomez JM. Quality of life in end-stage renal disease patients. Am J Kidney Dis. 2001; 38:443–64.PubMedCrossRefGoogle Scholar
  4. 4.
    Epstein RS, Sherwood LM. From outcomes research to disease management: a guide for the perplexed. Ann Intern Med. 1996;1:832–7.CrossRefGoogle Scholar
  5. 5.
    Vonesh EF, Schaubel DE, Hao W, Collins AJ. Statistical methods for comparing mortality among ESRD patients: examples of regional/international variations. Kidney Int. 2000;57(Suppl. 74):19–27.CrossRefGoogle Scholar
  6. 6.
    Sato T. A method for the analysis of repeated binary outcomes in randomized clinical trials with non-compliance. Stat Med. 2001;20:2761–74.PubMedCrossRefGoogle Scholar
  7. 7.
    Held PJ, Port FK, Wolfe RA et al. The dose of hemodialysis and patient mortality. Kidney Int. 1996;50:550–6.PubMedCrossRefGoogle Scholar
  8. 8.
    Owen W, Lew N, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as praetors of mortality in patients undergoing hemodialysis. N Engl J Med. 1993;329:1001–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Gotch FA, Levin NW, Port FK, Wolfe RA, Uehlinger DE. Clinical outcome relative to the dose of dialysis is not what you think: the fallacy of the mean. Am J Kidney Dis. 1997; 30:1–15.PubMedCrossRefGoogle Scholar
  10. 10.
    Fenton SSA, Schaubel DE, Desmeules M et al. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis. 1997;30:334–42.PubMedCrossRefGoogle Scholar
  11. 11.
    Schena FP. Epidemiology of end-stage renal disease: international comparisons of renal replacement therapy. Kidney Int. 2000;57(Suppl. 74):39–45.CrossRefGoogle Scholar
  12. 12.
    Schena FP. Report on the first meeting of the Chairmen of the National and International Registries. Kidney Int. 1997; 52:1422.CrossRefGoogle Scholar
  13. 13.
    Gotch F, Lipps B, Weaver J Jr et al. Chronic hemodialysis with the hollow fiber artificial kidney (HFAK). Trans Am Soc Artif Intern Organs. 1969;15:87–96.PubMedGoogle Scholar
  14. 14.
    Bergstrom J, Furst P, Zimmerman L. Uremic middle molecules exist and are biologically active. Clin Nephrol. 1979; 11:229–38.Google Scholar
  15. 15.
    Depner T, Beck G, Dirdas J, Kusek J, Eknoyan G. Lessons from the Hemodialysis (HEMO) Study: an improved measure of the actual hemodialysis dose. Am J Kidney Dis. 1999; 33:142–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Fatica RA, Port FK, Young EW. Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States. Am J Kidney Dis. 2001; 37:1184–90.PubMedCrossRefGoogle Scholar
  17. 17.
    Garg PP, Diener-West M, Powe NR. Income-based disparities in outcomes for patients with chronic kidney disease. Semin Nephrol. 2001;21:377–85.PubMedCrossRefGoogle Scholar
  18. 18.
    Parsons DA, Tracy SE, Handa KA, Greig PD. An update of the Canadian Organ Replacement Register (1998). Clin Transpl. 1998:97–106.Google Scholar
  19. 19.
    Murphy SW, Foley RN, Barrett BJ et al. Comparative mortality of hemodialysis and peritoneal dialysis in Canada. Kidney Int. 2000;57:1720–6.PubMedCrossRefGoogle Scholar
  20. 20.
    Schaubel DE, Fenton SS. Trends in mortality rates on hemodialysis in Canada, 1981–1997. Kidney Int. 2000;57 (Suppl. 74):66–73.CrossRefGoogle Scholar
  21. 21.
    Schaubel DE, Fenton SS. Trends in mortality on peritoneal dialysis: Canada, 1981–1997. J Am Soc Nephrol. 2000;11: 126–33.PubMedGoogle Scholar
  22. 22.
    Usami T, Koyama K, Takeuchi O, Morozumi K, Kimura G. Regional variations in the incidence of end-stage renal failure in Japan. J Am Med Assoc. 2000;284:2622–4.CrossRefGoogle Scholar
  23. 23.
    Shinzato T, Nakai S, Akiba T et al. Report of the annual statistical survey of the Japanese Society for Dialysis Therapy in 1996. Kidney Int. 1999;55:700–12.PubMedCrossRefGoogle Scholar
  24. 24.
    Akiba T, Nakai S, Shinzato T et al. Why has the gross mortality of dialysis patients increased in Japan? Kidney Int. 2000;57(Suppl. 74):60–65.CrossRefGoogle Scholar
  25. 25.
    Disney AP. Some trends in chronic renal replacement therapy in Australia and New Zealand, 1997. Nephrol Dial Transplant. 1998;13:854–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Disney AP. Demography and survival of patients receiving treatment for chronic renal failure in Australia and New Zealand: report on dialysis and renal transplantation treatment from the Australia and New Zealand Dialysis and Transplant Registry. Am J Kidney Dis. 1995;25:165–75.PubMedCrossRefGoogle Scholar
  27. 27.
    Van Biesen W, Wiedemann M, Lameire N. End-stage renal disease treatment: a European perspective. J Am Soc Nephrol. 1998;9(Suppl. 12):S55–62.PubMedGoogle Scholar
  28. 28.
    van Dijk PC, Jager KJ, de Charro F et al. ERA-EDTA registry. Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant. 2001;16:1120–9.PubMedCrossRefGoogle Scholar
  29. 29.
    Elinder CG, Jones E, Briggs JD et al. Improved survival in renal replacement therapy in Europe between 1975 and 1992. An ERA-EDTA Registry study. Nephrol Dial Transplant. 1999;14:2351–6.PubMedCrossRefGoogle Scholar
  30. 30.
    Schwedt E, Fernandez J, Gonzalez F, Mazzuchi N. Renal replacement therapy in Latin America during 1991–1995. Latin American Registry Committee. Transplant Proc. 1999; 31:3083–4.PubMedCrossRefGoogle Scholar
  31. 31.
    Ross S, Dong E, Gordon M et al. Meta-analysis of outcome studies in end-stage renal disease. Kidney Int. 2000;57(Suppl. 74): 28–38.CrossRefGoogle Scholar
  32. 32.
    Collins AJ, Ma JZ, Ebben J. Impact of hematocrit on morbidity and mortality. Semin Nephrol. 2000;20:345–9.PubMedGoogle Scholar
  33. 33.
    Bloembergen WE, Port FK, Mer EA, Wolfe RA. A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol. 1995;6:184–91.PubMedGoogle Scholar
  34. 34.
    Vonesh EF, Moran J. Mortality in end-stage renal disease: a reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol. 1999;10:354–65.PubMedGoogle Scholar
  35. 35.
    Xue JL, Chen SC, Ebben JP et al. Peritoneal and hemodialysis: I. Differences in patient characteristics at initiation. Kidney Int. 2002;61:734–40.PubMedCrossRefGoogle Scholar
  36. 36.
    Murphy SW, Foley RN, Barrett BJ et al. Comparative hospitalization of hemodialysis and peritoneal dialysis patients in Canada. Kidney Int. 2000;57:2557–63.PubMedCrossRefGoogle Scholar
  37. 37.
    Fenton SS, Schaubel DE, Desmeules M et al. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis. 1997;30:334–42.PubMedCrossRefGoogle Scholar
  38. 38.
    European Dialysis and Transplant Association. Report on Management of Renal Failure in Europe. XXV, 1994. Nephrol Dial Transplant. 1996;11(Suppl. 1):1–32.Google Scholar
  39. 39.
    Locatelli F, Mastrangelo F, Redaelli B et al. and the Italian Cooperative Dialysis Study Group. Effect of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. Kidney Int. 1996;50:1293–302.PubMedCrossRefGoogle Scholar
  40. 40.
    Leavey SF, Strawderman RL, Jones CA, Port FK, Held PJ. Simple nutritional inators as independent praetors of mortality in hemodialysis patients. Am J Kidney Dis. 1998;31: 997–1006.PubMedCrossRefGoogle Scholar
  41. 41.
    Mitch W, McClellan M. Patterns of patient care reported by nephrologists: implications for nephrology training. Am J Kidney Dis. 1998;32:551–6.PubMedCrossRefGoogle Scholar
  42. 42.
    McClellan WM, Soucie JM, Flanders WD. Mortality in endstage renal disease is associated with facility to facility differences in adequacy of hemodialysis. J Am Soc Nephrol. 1998;9:1940–7.PubMedGoogle Scholar
  43. 43.
    Lameire NP. Patient referral and dialysis initiation practices: a European perspective. When should we begin dialysis therapy? Official Satellite Symposium of ASN ’s 30th Annual Scientific Meeting and Exposition, 1997;11–18.Google Scholar
  44. 44.
    Woods JD, Port FK. The impact of vascular access for haemodialysis on patient morbidity and mortality. Nephrol Dial Transplant. 1997;12:657–9.PubMedCrossRefGoogle Scholar
  45. 45.
    Held PJ, Brunner F, Odaka M, Garcia J, Port FK, Gaylin DS. Five year survival for end stage renal disease patients in the US, Europe and Japan 1982–87. Am J Kidney Dis. 1990; 15:451–7.PubMedGoogle Scholar
  46. 46.
    Pei YP, Greenwood CM, Chery AL, Wu GG. Racial differences in survival of patients on dialysis. Kidney Int. 2000; 58:1293–9.PubMedCrossRefGoogle Scholar
  47. 47.
    Wong JS, Port FK, Hulbert-Shearon TE et al. Survival advantage in Asian American end-stage renal disease patients. Kidney Int. 1999;55:2515–23.PubMedCrossRefGoogle Scholar
  48. 48.
    Young EW, Goodkin DA, Mapes DL et al. The Dialysis Outcomes and Practice Pattern Study (DOPPS): an international hemodialysis study. Kidney Int. 2000;57(Suppl. 74): S74–81.CrossRefGoogle Scholar
  49. 49.
    Goodkin DA, Mapes DL, Held PJ. The dialysis outcomes and practice patterns study (DOPPS): how can we improve the care of hemodialysis patients? Semin Dial. 2001;14:157–9.PubMedCrossRefGoogle Scholar
  50. 50.
    Port FK, Orzol SM, Held PJ, Wolfe RA. Trends in treatment and survival for hemodialysis patients in the United States. Am J Kidney Dis. 1998;32(Suppl. 4):S34–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2004

Authors and Affiliations

  • D. Bottalico
  • F. K. Port
  • F. P. Schena

There are no affiliations available

Personalised recommendations